Dr. Michael Charlton has joined the University Chicago of Medicine as Professor of Medicine, Co-Director of the Transplantation Institute, and Director of Hepatology effective March 13th. As Co-Director of the Transplantation Institute, Dr. Charlton will work closely with medical and administrative leadership in the development and execution of a strategic vision for the Transplantation Institute to not only improve programmatic quality and volume, but also increase overall market share.

Dr. Charlton joins the University Chicago of Medicine after most recently serving as Director of the Intermountain Transplant and Regenerative Medicine Center in Utah. Prior to his role at Intermountain, Dr. Charlton was the Director of Hepatology and Medical Director of Liver Transplantation at the Mayo Clinic in Rochester, Minnesota.

Dr. Charlton will also be joining Dr. David Rubin and Dr. Eugene Chang as one of the GI Research Foundation medical and scientific advisors.

Dr. Charlton is the current President of the International Liver Transplant Society and is a member of numerous professional societies. He is a member of the AASLD NAFLD Practice Guidelines writing group. In addition, he is an Associate Editor for the American Journal of Transplantation. He has served as an Associate Editor for Hepatology, Liver Transplantation and was a founding Associate Editor for Clinical Gastroenterology and Hepatology.

Dr. Charlton’s clinical practice areas of focus are liver transplantation, non-alcoholic fatty liver disease and viral hepatitis. Dr. Charlton has been a principal investigator in several National Institutes of Health grants including a study of the pathobiological basis of the histological spectrum of non-alcoholic fatty liver disease.